These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6138719

  • 1. [Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model].
    Gaebel W, Pietzcker A.
    Nervenarzt; 1983 Sep; 54(9):467-76. PubMed ID: 6138719
    [No Abstract] [Full Text] [Related]

  • 2. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
    Müller P.
    Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [Abstract] [Full Text] [Related]

  • 4. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D.
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [Abstract] [Full Text] [Related]

  • 5. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W, Kilian R, Toumi M, Angermeyer MC.
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [Abstract] [Full Text] [Related]

  • 6. [Can psycho-education of chronic schizophrenic patients have a short-term effect on drug-related attitude and behavior?].
    Hornung WP, Franzen U, Lemke R, Wiesemann C, Buchkremer G.
    Psychiatr Prax; 1993 Jul; 20(4):152-4. PubMed ID: 8103230
    [Abstract] [Full Text] [Related]

  • 7. [Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses].
    Möller HJ, von Zerssen D.
    Nervenarzt; 1985 Sep; 56(9):498-505. PubMed ID: 2867479
    [No Abstract] [Full Text] [Related]

  • 8. Clozapine maintenance therapy in schizophrenia.
    Gaszner P, Makkos Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A, Goudemand M, Thomas P.
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment and course of schizophrenic psychoses over a decade. Disease course and predictors].
    Müller P, Günther U, Lohmeyer J.
    Nervenarzt; 1986 Jun; 57(6):332-41. PubMed ID: 2874507
    [No Abstract] [Full Text] [Related]

  • 14. [The analysis of factors prior to positive symptoms relapse in schizophrenia].
    Melcer P, Rabe-Jabłońska J.
    Psychiatr Pol; 2002 Jun; 36(6 Suppl):271-81. PubMed ID: 12647449
    [Abstract] [Full Text] [Related]

  • 15. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC.
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [Abstract] [Full Text] [Related]

  • 16. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.
    Duncan JC, Rogers R.
    J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389
    [Abstract] [Full Text] [Related]

  • 17. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT, Rada RT.
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [Abstract] [Full Text] [Related]

  • 18. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.
    Encephale; 1995 May; 21(6):417-24. PubMed ID: 8674466
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.